newsfilter
← Latest News
GlobeNewswire·

ProMIS Neurosciences to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

CAMBRIDGE, Massachusetts and TORONTO, Ontario, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (NASDAQ:PMN), a clinical-stage biotechnology company focused on the generation and development of antibody